New York, NY (Vocus) May 25, 2010
Prize4Life (http://www.prize4life.org), a nonprofit organization founded to accelerate the discovery of treatments and a cure for ALS/Lou Gehrig's disease, will be hosting its “Art, Life, Spring” gala and charity auction at the Roger Smith Hotel on Thursday, May 27. The auction will feature works by top artists to raise funds for its mission. A companion online auction will be open through June 3, at (http://www.charitybuzz.com/ Prize4Life).
Prize4Life is a non-profit organization dedicated to treating and curing ALS (Lou Gehrig's Disease) using a combination of the incentive prize model and other crowd-sourcing and distributed innovation approaches. The organization currently administers the $1 million ALS Treatment Prize and the $1 million ALS Biomarker Challenge, along with a host of other scientific and clinical resources.
"Prize4Life is thrilled to be hosting this event. Thanks to the overwhelming generosity of our sponsors and artists, we have an incredible selection of lots. One hundred percent of the proceeds will go directly to ending ALS/Lou Gehrig's Disease through our innovative programs,” said Avi Kremer, co-founder and CEO of Prize4Life, and an ALS patient.
The auction includes work by sculptors Boaz Vaadia, John Bisbee, and Tim Prentice; painters Miriam Cabessa, Natan Elkanovich, Engels, and Carol Anthony; photographers Isack Kousnsky, Nancy Rudolph, Tal Shochat, and Nobel laureate Wally Gilbert, among others. The event will take place at the Roger Smith Hotel, a classy, dynamic venue in midtown Manhattan, home to The Lab gallery for performance and installation, and host of two regular music series.
A pre-auction art showing and cocktail reception was held at Sotheby's Auction House on Thursday, May 20. Speakers included Jamie Niven, Chairman of Sotheby’s North and South America, and Gabriela Shalev, Israeli Ambassador to the United Nations.
Works available for online bidding in the Prize4Life live and online auctions include:
Online Bidding in the “Art, Life, Spring” Auction is open to the global community through June 3. Go to http://www.charitybuzz.com/Prize4Life to place a bid.
The A.L.S. Gala Auction has been generously sponsored by Bloomberg LP, Vertex Pharmaceuticals, Biogen IDEC, Bristol-Myers Squibb, Sotheby’s, and the Roger Smith Hotel.
For more information on the Prize4Life auction, please visit http://www.Prize4Life.org.
Known in the United States as Lou Gehrig’s Disease, ALS is a rapidly progressing neurodegenerative disease that typically takes the life of patients within 2-5 years of diagnosis. It is caused by the degeneration of motor neurons, the nerve cells in the central nervous system that control voluntary muscle movement. It most commonly strikes people between the ages of 40 and 70, and affects men slightly more than women. ALS is the most common motor neuron disease worldwide and as many as 30,000 Americans struggle with it at any given time. There is no known cure for ALS and only one modestly effective FDA-approved treatment for the disease.
Prize4Life was founded by a group of Harvard Business School students when one of them, Avi Kremer, was diagnosed with ALS at the age of 29. Prize4Life works to accelerate the discovery of a treatment and a cure for ALS by using powerful incentives to attract new people and ideas, and to leverage existing efforts and expertise in the ALS field. Among other program initiatives, the organization currently administers the ALS Biomarker Prize Challenge, the Avi Kremer ALS Treatment Prize, and an ALS research portal (http://www.ResearchALS.org).